(90 days)
No
The device description and performance studies focus on the physical properties and sterile water content of a pre-filled syringe, with no mention of AI or ML capabilities.
No
The device is described as a pre-filled syringe for inflating Foley catheter balloons, which is a supportive function for a therapeutic device (Foley catheter) but is not itself performing a therapeutic action on the body.
No
The device is described as a pre-filled syringe for inflating foley catheter balloons, a purely mechanical function. There is no information suggesting it is used for diagnosis, disease detection, or monitoring.
No
The device description clearly outlines a physical syringe made of polypropylene and rubber, pre-filled with water. There is no mention of software as a component or the primary function of the device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is clearly stated as "for foley catheter balloon inflation." This is a mechanical function used to secure a medical device within the body.
- Device Description: The description details a syringe pre-filled with purified water for a physical action (inflating a balloon).
- Lack of Diagnostic Purpose: There is no mention of the device being used to examine specimens derived from the human body to provide information for the diagnosis, prevention, monitoring, treatment, or alleviation of disease.
IVD devices are used to perform tests on samples like blood, urine, or tissue to gain diagnostic information. This device performs a physical action within the body and does not involve the analysis of biological specimens for diagnostic purposes.
N/A
Intended Use / Indications for Use
The 10cc and 30cc pre-filled syringes are intended to be used for foley catheter balloon inflation.
Product codes
EZL
Device Description
The device is a single-use 10cc and 30cc syringe pre-filled with USP purified water and gamma irradiated. The device has two models, PCAA01 and PCAA03. They are only different in volume; PCAA01 is 10cc, and PCAA03 is 30cc. The syringe is produced using polypropylene for the device barrel and plunger and pharmaceutical grade latex free rubber for both the plunger gasket and protect cap. The device contacts indirectly with the human body. The duration of contact is less than 24 hours. The product is used in conjunction with the urinary catheter to push the plunger of the syringe to inject the sterilized pre-filled purified water into the balloon of the urinary catheter to inflate the balloon.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Biocompatibility testing:
The biocompatibility evaluation for the Prefilled Syringe was conducted in accordance with the International Standard ISO 10993-1:2018, "Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process" as recognized by FDA. The biocompatible testing included the following tests:
- Cytotoxicity - (ISO 10993-5: 2009)
- Sensitization - (ISO 10993-10:2010)
- Irritation - (ISO 10993-10:2010)
Performance testing:
Performance testing was conducted on the Prefilled Syringe according to the following standards:
-
- ISO 7886-1: 2017 Sterile hypodermic syringes for single use Part 1: Syringes for manual use
-
- ISO 11040-8: 2016 Prefilled Syringes Requirements and test methods for finished prefilled syringes
-
- ISO 11040-4: 2015 Prefilled Syringes Glass barrels for injectables and sterilized subassembled syringes ready for filling
-
- ISO 11040-6: 2019 Prefilled Syringes Plastic barrels for injectables and sterilized subassembled syringes ready for filling
-
- ISO 80369-1: 2018 Small-bore connectors for liquids and gases in healthcare applications - Part 1: General requirements
-
- ISO 80369-7: 2016 Small-bore connectors for liquids and gases in healthcare applications - Part 7: Connectors for intravascular or hypodermic applications
-
- ISO 80369-20: 2015 Small-bore connectors for liquids and gases in healthcare applications - Part 20: Common test methods
-
- USP 40 Purified Water
All of the tested parameters met the predefined acceptance criteria.
From the results of non-clinical data including the performance testing described, it is concluded that the Prefilled Syringe is as safe and as effective as the predicate device. The information provided within this pre-market notification demonstrates that the device is substantially equivalent to the predicate device.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 876.5130 Urological catheter and accessories.
(a)
Identification. A urological catheter and accessories is a flexible tubular device that is inserted through the urethra and used to pass fluids to or from the urinary tract. This generic type of device includes radiopaque urological catheters, ureteral catheters, urethral catheters, coudé catheters, balloon retention type catheters, straight catheters, upper urinary tract catheters, double lumen female urethrographic catheters, disposable ureteral catheters, male urethrographic catheters, and urological catheter accessories including ureteral catheter stylets, ureteral catheter adapters, ureteral catheter holders, ureteral catheter stylets, ureteral catheterization trays, and the gastro-urological irrigation tray (for urological use).(b)
Classification. (1) Class II (performance standards).(2) Class I for the ureteral stylet (guidewire), stylet for gastrourological catheter, ureteral catheter adapter, ureteral catheter connector, and ureteral catheter holder. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.
0
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
December 15, 2020
Hangzhou Primecare Medical Co., Ltd. % Olivia Meng Regulatory Affairs Manager Guangzhou Osmunda Medical Device Technical Service Co., Ltd. 8-9th Floor, R&D Building, No.26 Qinglan Street, Panyu District Guangzhou, Guangdong 510006 China
Re: K202698
Trade/Device Name: Prefilled Syringe Regulation Number: 21 CFR§ 876.5130 Regulation Name: Urological Catheter and Accessories Regulatory Class: II Product Code: EZL Dated: September 11, 2020 Received: September 16, 2020
Dear Olivia Meng:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies.
You must comply with all the Act's requirements. including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatoryinformation/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Sharon M. Andrews Director DHT3B: Division of Reproductive, Gynecology and Urology Devices OHT3: Office of GastroRenal, ObGyn, General Hospital and Urology Devices Office of Product Evaluation and Ouality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K202698
Device Name Prefilled Syringe
Indications for Use (Describe)
The 10cc and 30cc pre-filled syringes are intended to be used for foley catheter balloon inflation.
Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)
| Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
510(k) Summary – K202698
In accordance with 21 CFR 807.92 the following summary of information is provided:
1. SUBMITTER
Hangzhou Primecare Medical Co., Ltd. Room 408-409, Zancheng Center West, Shangcheng District, 310008 Hangzhou, Zhejiang Province, PEOPLE'S REPUBLIC OF CHINA Phone: +86-13357148752 Fax: +86-0571-81958625
Primary Contact | Olivia Meng |
---|---|
Person: | Regulatory Affairs Manager |
Guangzhou Osmunda Medical Device Technical Service | |
Co., Ltd. | |
Tel: (+86)-20-6231 6262 | |
Fax: (+86)-20-8633 0253 | |
Secondary Contact | Xueqing Yan |
Person: | Quality Supervisor |
Hangzhou Primecare Medical Co., Ltd. | |
Phone: +86-13357148752 | |
Fax: +86-0571-81958625 | |
Date prepared | December 15, 2020 |
2. DEVICE | |
Device Name: | Prefilled Syringe |
Common name: | Prefilled Syringe |
Model: | PCAA01, PCAA03 |
Regulation Number | 21 CFR 876.5130 |
Regulation Name | Urological catheter and accessories |
Regulatory Class: | 2 |
Product Code: | EZL |
Product Code Name: | Catheter, Retention Type, Balloon |
- PREDICATE DEVICE
4
K030813, Primary Care Solutions Prefilled 10cc and Prefilled 30cc Inflation Syringes with Sterile Water; Catalog numbers 1010 and 1030 respectively This predicate has not been subject to a design-related recall.
DEVICE DESCRIPTION 4.
The device is a single-use 10cc and 30cc syringe pre-filled with USP purified water and gamma irradiated. The device has two models, PCAA01 and PCAA03. They are only different in volume; PCAA01 is 10cc, and PCAA03 is 30cc. The syringe is produced using polypropylene for the device barrel and plunger and pharmaceutical grade latex free rubber for both the plunger gasket and protect cap. The device contacts indirectly with the human body. The duration of contact is less than 24 hours. The product is used in conjunction with the urinary catheter to push the plunger of the syringe to inject the sterilized pre-filled purified water into the balloon of the urinary catheter to inflate the balloon.
5. INDICATIONS FOR USE
The 10cc and 30cc pre-filled syringes are intended to be used for foley catheter balloon inflation.
The intended use of the device is the same as the intended use of the predicate device.
| | Predicate Device | Proposed Device | Discussion of
Differences | |
|------------------------|----------------------------------------------------------------------------------------------------------|---------------------------------------------|------------------------------|------|
| Device name | Primary Care Solutions
Prefilled 10cc and Prefilled
30cc Inflation Syringes
with Sterile Water; | Prefilled Syringe | | |
| K number | K030813 | K202698 | | |
| Size | 10cc and 30cc | 10cc and 30cc | Same | |
| Principle of operation | Manual | Manual | Same | |
| Design | Conforms with ISO 7886.1
and ISO 80369-7 | Conforms with ISO 7886.1
and ISO 80369-7 | Same | |
| Disposable? | Disposable for single use | Disposable for single use | Same | |
| Materials
Of | Barrel | Polypropylene | Polypropylene | Same |
COMPARISON OF TECHNOLOGICAL CHARACTERISTICS WITH THE PREDICATE DEVICE 6.
5
| Main
Components | Plunger | Polypropylene | Polypropylene | |
---|---|---|---|---|
Stopper | Pharmaceutical Grade | |||
Latex Free Rubber | Pharmaceutical Grade Latex | |||
Free Rubber | ||||
Protective Cap | Pharmaceutical Grade | |||
Latex Free Rubber | Pharmaceutical Grade Latex | |||
Free Rubber | ||||
Solution | Purified Water, USP | Purified Water, USP | ||
Sterile? | Sterile (gamma irradiation) | Sterile (gamma irradiation) | Same |
As evidenced by the table above, the subject and predicate device have similar technological characteristics.
7. PERFORMANCE DATA
The following performance data were provided in support of the substantial equivalence determination.
Biocompatibility testing
The biocompatibility evaluation for the Prefilled Syringe was conducted in accordance with the International Standard ISO 10993-1:2018, "Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process" as recognized by FDA. The biocompatible testing included the following tests:
- Cytotoxicity - (ISO 10993-5: 2009)
- Sensitization - (ISO 10993-10:2010)
- Irritation - (ISO 10993-10:2010)
Performance testing
Performance testing was conducted on the Prefilled Syringe according to the following standards:
-
- ISO 7886-1: 2017 Sterile hypodermic syringes for single use Part 1: Syringes for manual use
-
- ISO 11040-8: 2016 Prefilled Syringes Requirements and test methods for finished prefilled syringes
-
- ISO 11040-4: 2015 Prefilled Syringes Glass barrels for injectables and sterilized subassembled syringes ready for filling
6
-
- ISO 11040-6: 2019 Prefilled Syringes Plastic barrels for injectables and sterilized subassembled syringes ready for filling
-
- ISO 80369-1: 2018 Small-bore connectors for liquids and gases in healthcare applications - Part 1: General requirements
-
- ISO 80369-7: 2016 Small-bore connectors for liquids and gases in healthcare applications - Part 7: Connectors for intravascular or hypodermic applications
-
- ISO 80369-20: 2015 Small-bore connectors for liquids and gases in healthcare applications - Part 20: Common test methods
-
- USP 40 Purified Water
All of the tested parameters met the predefined acceptance criteria.
CONCLUSION 8.
From the results of non-clinical data including the performance testing described, it is concluded that the Prefilled Syringe is as safe and as effective as the predicate device. The information provided within this pre-market notification demonstrates that the device is substantially equivalent to the predicate device.